Glucose-Lowering Medications and Risk of Chronic Obstructive Pulmonary Disease Exacerbations in Patients With Type 2 Diabetes

医学 慢性阻塞性肺病 2型糖尿病 危险系数 内科学 糖尿病 恶化 耐受性 艾塞那肽 重症监护医学 数据库 不利影响 置信区间 内分泌学 计算机科学
作者
Avik Ray,Julie M. Paik,Deborah J. Wexler,Sushama Kattinakere Sreedhara,Katsiaryna Bykov,William B. Feldman,Elisabetta Patorno
出处
期刊:JAMA Internal Medicine [American Medical Association]
被引量:2
标识
DOI:10.1001/jamainternmed.2024.7811
摘要

Importance Recent studies have suggested that sodium-glucose cotransporter-2 inhibitors (SGLT-2is), glucagon-like peptide-1 receptor agonists (GLP-1RAs), and dipeptidyl peptidase 4 inhibitors (DPP-4is) may benefit patients with chronic obstructive pulmonary disease (COPD). However, clinical evidence is lacking on their comparative association with COPD exacerbations in US patients with type 2 diabetes (T2D). Objective To compare the risk of moderate or severe COPD exacerbations among SGLT-2is, GLP-1RAs, and DPP-4is. Design, Setting, and Participants This comparative effectiveness research study used data from three 1:1 propensity score–matched cohort studies that emulated 3 target trials comparing patients 40 years or older with T2D and active COPD who initiated treatment with SGLT-2is vs DPP-4is, GLP-1RAs vs DPP-4is, and SGLT-2is vs GLP-1RAs. Data were from 3 US insurance claims databases: the Optum deidentified Clinformatics Data Mart Database (2013-2023), IBM Health MarketScan (2013-2021), and Medicare fee for service (2013-2020). The data analysis was conducted from January to June 2024. Exposures Initiation of SGLT-2i or DPP-4i, GLP-1RA or DPP-4i, and SGLT-2i or GLP-1RA for the 3 target trials, respectively. Main Outcomes and Measures First occurrence of a moderate or severe COPD exacerbation, defined as a filled prescription for oral glucocorticoids in association with an outpatient COPD visit or hospitalization for COPD. Incidence rates, incidence rate differences (IRDs), and hazard ratios (HRs) with 95% CIs were calculated. Results There were 27 991, 32 107, and 36 218 pairs in the SGLT-2i vs DPP-4i, GLP-1RA vs DPP-4i, and SGLT-2i vs GLP-1RA propensity score–matched cohorts, respectively (mean [SD] age, 70.8 [8.6] and 70.7 [8.8], 70.4 [8.5] and 70.4 [8.2], and 69.8 [8.7] years, respectively; 13 767 [49.2%] and 13 847 [49.5%], 17 622 [54.9%] and 17 620 [54.9%], and 18 807 [51.9%] and 18 854 [52.1%] female individuals, respectively). During a median follow-up of 145 (IQR, 61-355) days of treatment, the risk of moderate or severe COPD exacerbation was lower among those treated with SGLT-2is vs DPP-4is (9.26 vs 11.4 per 100 person-years [PYs]; HR, 0.81; 95% CI, 0.76-0.86; IRD/100 PYs, −2.20; 95% CI, −2.83 to −1.58) and among those treated with GLP-1RAs vs DPP-4is (9.89 vs 11.49 per 100 PYs; HR, 0.86; 95% CI, 0.81-0.91; IRD/100 PYs, −1.60; 95% CI, −2.18 to −1.02), with minimal differences among those treated with SGLT-2is vs GLP-1RAs (9.47 vs 10.00 per 100 PYs; HR, 0.94; 95% CI, 0.89-1.00; IRD/100 PYs, −0.55; 95% CI, −1.09 to −0.01). Results were consistent across sensitivity and subgroup analyses. Conclusions and Relevance The results of this comparative effectiveness research study suggest that SGLT-2is and GLP-1RAs were associated with a reduced risk of moderate or severe COPD exacerbations compared with DPP-4i in adults with T2D and active COPD. This may inform prescribing of glucose-lowering medications among patients with T2D and active COPD.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
桐桐应助zdy采纳,获得10
刚刚
1秒前
爆米花应助纯真雁菱采纳,获得10
1秒前
yggmdggr完成签到,获得积分10
2秒前
zizhuo2完成签到,获得积分10
2秒前
2秒前
2秒前
呆萌的雁荷完成签到,获得积分10
2秒前
猪猪hero发布了新的文献求助10
2秒前
热情蜗牛完成签到 ,获得积分20
2秒前
蹄子发布了新的文献求助10
3秒前
逃之姚姚完成签到 ,获得积分10
3秒前
李健的小迷弟应助caiiiii采纳,获得10
3秒前
4秒前
Lucas应助花生了什么树采纳,获得10
4秒前
4秒前
来日可追应助realssr采纳,获得10
4秒前
友好曲奇发布了新的文献求助10
4秒前
zero发布了新的文献求助10
5秒前
可靠往事发布了新的文献求助10
5秒前
美丽稀完成签到,获得积分10
5秒前
Warten995完成签到,获得积分10
5秒前
6秒前
赫连立果完成签到,获得积分10
6秒前
yll完成签到,获得积分10
6秒前
温柔海冬发布了新的文献求助10
6秒前
天骄928发布了新的文献求助10
6秒前
6秒前
清爽老九发布了新的文献求助10
7秒前
7秒前
7秒前
7秒前
今后应助博修采纳,获得10
8秒前
vgh完成签到,获得积分10
8秒前
万能图书馆应助轩辕德地采纳,获得10
8秒前
8秒前
lysixsixsix发布了新的文献求助10
9秒前
酷炫的电源完成签到 ,获得积分10
9秒前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2700
Les Mantodea de Guyane Insecta, Polyneoptera 1000
Structural Load Modelling and Combination for Performance and Safety Evaluation 1000
Conference Record, IAS Annual Meeting 1977 820
England and the Discovery of America, 1481-1620 600
電気学会論文誌D(産業応用部門誌), 141 巻, 11 号 510
Exploring the effects of an evidenced-based professional development programme on teaching and learning in Chinese kindergartens 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3575829
求助须知:如何正确求助?哪些是违规求助? 3145814
关于积分的说明 9462629
捐赠科研通 2847348
什么是DOI,文献DOI怎么找? 1565047
邀请新用户注册赠送积分活动 732801
科研通“疑难数据库(出版商)”最低求助积分说明 719361